The hypoxic tumour microenvironment contributes to tumour progression by activating a series of adaptive responses that include tumour neovascularisation and tumour-specific immune responses, mediated through the key transcriptional regulators HIF-1α and HIF-2α. The gene discussed is HIF1A; the disease is neoplasm.